Connect the Dots

Back to FDA accelerated approval of Aduhelm (2021)

The story of FDA accelerated approval of Aduhelm (2021)

The FDA's 7 June 2021 accelerated approval of Biogen's Alzheimer's drug Aduhelm.

4 scenes, drawn from sourced links. Scroll to play, or press Watch.

7 Jun 2021

FDA accelerated approval of Aduhelm (2021). The FDA’s 7 June 2021 accelerated approval of Biogen’s Alzheimer’s drug Aduhelm.

FDA accelerated approval of Aduhelm (2021) involved U.S. Food and Drug Administration, Biogen and Aduhelm.

FDA accelerated approval of Aduhelm (2021) led to House staff report on Aduhelm (2022).

4 sourced connections, each with its evidence. Open the explorer to follow any of them further, filter by lens, or move through time.

Explore from here

Drawn from the sourced links on FDA accelerated approval of Aduhelm (2021). Change a link and this story changes with it.